Immunome

Immunome IMNM Stock

$17.61   -6.180074%
Add to favorites
Market Cap
$2.08B
LOW - HIGH [24H]
$17.55 - $19.15
VOLUME [24H]
$1.52M
P/E Ratio
0
Earnings per share
-$2.63
ISIN
US45257U1088
Price   Prediction

Immunome Price Chart

Sorry, that's all we've gotfor now...

Immunome (IMNM) stock price today is 17.61 USD on Tech Market Small (-6.18% on the day). Updated .

Immunome IMNM Financial and Trading Overview

Immunome stock price 17.61 USD
Previous Close 18.77 USD
Open 18.5 USD
Bid 13.61 USD x 200
Ask 17.97 USD x 100
Day's Range 17.55 - 19.15 USD
52 Week Range 16.41 - 30.06 USD
Volume 1.52M USD
Avg. Volume 1.38M USD
Market Cap 2.08B USD
Beta (5Y Monthly) 2.662
PE Ratio (TTM) N/A
EPS (TTM) -2.63 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 35.13 USD

IMNM Valuation Measures

Enterprise Value 1.63B USD
Trailing P/E N/A
Forward P/E -6.9082127
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)
Price/Book (mrq) 4.4058046
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.666

Trading Information

Immunome Stock Price History

Beta (5Y Monthly) 2.662
52-Week Change 3.53%
S&P500 52-Week Change 13.32%
52 Week High 30.06 USD
52 Week Low 16.41 USD
50-Day Moving Average 20.65 USD
200-Day Moving Average 22.21 USD

IMNM Share Statistics

Avg. Volume (3 month) 1.38M USD
Avg. Daily Volume (10-Days) 1.73M USD
Shares Outstanding 118.07M
Float 113.15M
Short Ratio 11.77
% Held by Insiders 6.53%
% Held by Institutions 102.31%
Shares Short 16.17M
Short % of Float 15.92%
Short % of Shares Outstanding 13.71%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -45.14%
Return on Equity (ttm) -78.70%

Income Statement

Revenue (ttm) 0 USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -226542000 USD
EBITDA -287496000 USD
Net Income Avi to Common (ttm) -282648992 USD
Diluted EPS (ttm) -2.63
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 461.58M USD
Total Cash Per Share (mrq) 3.91 USD
Total Debt (mrq) 11.39M USD
Total Debt/Equity (mrq) 2.51 USD
Current Ratio (mrq) 11.663
Book Value Per Share (mrq) 3.997

Cash Flow Statement

Operating Cash Flow (ttm) -229034000 USD
Levered Free Cash Flow (ttm) -159733632 USD

Profile of Immunome

Country United States
State WA
City Bothell
Address 18702 North Creek Parkway
ZIP 98011
Phone 425 939 7410
Website https://immunome.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 267

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Q&A For Immunome Stock

What is a current IMNM stock price?

Immunome IMNM stock price today per share is 17.61 USD.

How to purchase Immunome stock?

You can buy IMNM shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Immunome?

The stock symbol or ticker of Immunome is IMNM.

Which industry does the Immunome company belong to?

The Immunome industry is Biotechnology.

How many shares does Immunome have in circulation?

The max supply of Immunome shares is 118.07M.

What is Immunome Price to Earnings Ratio (PE Ratio)?

Immunome PE Ratio is now.

What was Immunome earnings per share over the trailing 12 months (TTM)?

Immunome EPS is -2.63 USD over the trailing 12 months.

Which sector does the Immunome company belong to?

The Immunome sector is Healthcare.

Immunome IMNM included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24509.76 USD —
-2.49
8.22B USD — 24460.28 USD — 24882.04 USD — — 8.22B USD —
us US Tech Health Care IXHC US 1342.75 USD —
-1.87
— — 1340.49 USD — 1374 USD — — — —
$2.2T
Total marketcap
$78.55B
Total volume
BTC 59.22%   •   ETH 10.09%
Dominance
Select currency